®
About Us
Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.
With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.
Qualifications
BD13495[50913-12-7]N2-(tert-Butoxycarbonyl)-Nw-nitro-D-arginine*
Specific Information
| Purity : | 97% | Specific Rotation : | |
| NMR(H/C/F/S/P) : | E.E. : | ||
| HPLC : | Water Content : | ||
| Polymerization Inhibitor : | Single Impurity : | ||
| Melting Point : | Density : | ||
| Packaging : | Solubility : | ||
| Name Note : | Acetic Acid : | ||
| Beilstein : | Grade : | ||
| Specific Gravity : | Viscosity : | ||
| Others : | |||
Product Details
| Cat No. : | BD13495 | Synonyms : | N2-(tert-Butoxycarbonyl)-Nw-nitro-D-arginine |
| CAS No. : | 50913-12-7 | MDL NO : | MFCD00038091 |
| Formule : | C11H21N5O6 | InChI Key : | N/A |
| M.W : | 319.31 | Pubchem ID : | 7021876 |
| Boiling Point : | |||
Safety
| Signal Word : | Danger | Class : | 4.1 |
| Precautionary Statements : | P261-P210-P264-P280-P370+P378-P302+P352+P312 | UN# : | 1325 |
| Hazard Statements : | H302+H312+H332-H315-H319-H228 | Packing Group : | Ⅲ |
| GHS Pictogram: | |||
R&D Center
- +CONTACT
TM
Copyright © 2013-2024 BLDpharm. All Rights Reserved.
Research Use Only!